1. Home
  2. GNTA vs SNCR Comparison

GNTA vs SNCR Comparison

Compare GNTA & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTA
  • SNCR
  • Stock Information
  • Founded
  • GNTA 2014
  • SNCR 2000
  • Country
  • GNTA Italy
  • SNCR United States
  • Employees
  • GNTA N/A
  • SNCR N/A
  • Industry
  • GNTA Biotechnology: Biological Products (No Diagnostic Substances)
  • SNCR EDP Services
  • Sector
  • GNTA Health Care
  • SNCR Technology
  • Exchange
  • GNTA Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • GNTA 67.4M
  • SNCR 137.5M
  • IPO Year
  • GNTA 2021
  • SNCR 2006
  • Fundamental
  • Price
  • GNTA $5.34
  • SNCR $11.25
  • Analyst Decision
  • GNTA Strong Buy
  • SNCR
  • Analyst Count
  • GNTA 1
  • SNCR 0
  • Target Price
  • GNTA $25.00
  • SNCR N/A
  • AVG Volume (30 Days)
  • GNTA 28.4K
  • SNCR 81.2K
  • Earning Date
  • GNTA 01-01-0001
  • SNCR 11-12-2024
  • Dividend Yield
  • GNTA N/A
  • SNCR N/A
  • EPS Growth
  • GNTA N/A
  • SNCR N/A
  • EPS
  • GNTA N/A
  • SNCR N/A
  • Revenue
  • GNTA N/A
  • SNCR $167,615,000.00
  • Revenue This Year
  • GNTA N/A
  • SNCR $7.76
  • Revenue Next Year
  • GNTA N/A
  • SNCR $5.83
  • P/E Ratio
  • GNTA N/A
  • SNCR N/A
  • Revenue Growth
  • GNTA N/A
  • SNCR 33.39
  • 52 Week Low
  • GNTA $2.20
  • SNCR $2.70
  • 52 Week High
  • GNTA $7.28
  • SNCR $15.46
  • Technical
  • Relative Strength Index (RSI)
  • GNTA 56.89
  • SNCR 43.11
  • Support Level
  • GNTA $4.89
  • SNCR $10.45
  • Resistance Level
  • GNTA $6.20
  • SNCR $11.44
  • Average True Range (ATR)
  • GNTA 0.70
  • SNCR 0.57
  • MACD
  • GNTA -0.06
  • SNCR -0.06
  • Stochastic Oscillator
  • GNTA 37.32
  • SNCR 31.58

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: